Volume XXX, No. 14 – October 2, 2023
Table of Contents
Articles
FDA Issues Proposed Rule to Further Regulate LDTs
FDA’s Road to Regulation of Lab Developed Tests
SALSA Bill Resurfaces, Poised to Reduce Upcoming PAMA Cuts
Outreach Nets Hospital Lab $2.5M in One Year
How Private Payers Audit Labs for Possible Claims Fraud
Labcorp and Quest Discuss Outreach Acquisition Potential
Intelligence
Commentary & Opinion by R. Lewis Dark